| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 154, Issue 9 4333-4340, Copyright © 1995 by American Association of Immunologists
ARTICLES |
W Hashimoto, K Takeda, R Anzai, K Ogasawara, H Sakihara, K Sugiura, S Seki and K Kumagai
Department of Microbiology, Tohoku University School of Dentistry, Sendai, Japan.
Systemic administration of IL-12 greatly reduced the hepatic metastases of i.v.-injected liver metastatic EL4 tumor cells in C57BL/6 +/+ and nu/nu mice. Cytotoxic assay in vitro revealed that administration of IL- 12 greatly enhanced cytotoxicity of hepatic mononuclear cells (MNC) against various NK- sensitive and -resistant tumor targets, including EL4 cells, whereas only slight or moderate augmentation of the cytotoxicity was observed in splenocytes in normal and nude mice. After IL-12 administration, hepatic MNC increased in number and showed vigorous proliferation in vitro. Hepatic MNC of control C57BL/6 +/+ mice contain alpha beta T cells with intermediate TCR (TCRint) as well as alpha beta T cells with bright TCR, whereas hepatic MNC of nu/nu mice have only TCRint cells. These TCRint cells are found to be NK1.1 Ag+ (NK1+ TCRint). Systemic administration of IL-12 into normal and nude mice markedly augments the NK1 expression of NK1+ TCRint cells (NK1high TCRint), which is comparable to or brighter than that of NK cells in the liver, whereas alpha beta T cells with bright TCR or gamma delta T cells in the liver are NK1-. Depletion of either NK1.1+ or CD3+ cells, but not CD8+ cells, of hepatic MNC from IL-12-treated normal mice by respective Abs and C in vitro abrogate their cytotoxicity. These results revealed that TCRint cells are potent cytotoxic effector cells and suggest that NK1high TCRint cells are the main antimetastatic population in the liver, and that TCRint cells are functionally different from regular T cells with bright TCR.
This article has been cited by other articles:
|
|
 |
|
  S. Vasan, M. A. Poles, A. Horowitz, E. E. Siladji, M. Markowitz, and M. Tsuji Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection Int. Immunol., August 16, 2007; (2007) dxm055v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Vinay, B. K. Choi, J. S. Bae, W. Y. Kim, B. M. Gebhardt, and B. S. Kwon CD137-Deficient Mice Have Reduced NK/NKT Cell Numbers and Function, Are Resistant to Lipopolysaccharide-Induced Shock Syndromes, and Have Lower IL-4 Responses J. Immunol., September 15, 2004; 173(6): 4218 - 4229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nakagawa, T. Inui, I. Nagafune, Y. Tazunoki, K. Motoki, A. Yamauchi, M. Hirashima, Y. Habu, H. Nakashima, and S. Seki Essential Role of Bystander Cytotoxic CD122+CD8+ T Cells for the Antitumor Immunity Induced in the Liver of Mice by {alpha}-Galactosylceramide J. Immunol., June 1, 2004; 172(11): 6550 - 6557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kanoh, T. Shimura, H. Suzuki, K. Nomoto, T. Asao, and H. Kuwano Antitumor Effect of a Splenic Injection of 5-Fluorouracil on Metastatic Liver Cancer in Mice J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 168 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Bryson, L. Zhang, S. W. Goes, C. D. Jennings, B. E. Caywood, S. L. Carlson, and A. M. Kaplan CD4+ T Cells Mediate Murine Syngeneic Graft-versus-Host Disease-Associated Colitis J. Immunol., January 1, 2004; 172(1): 679 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Inui, R. Nakagawa, S. Ohkura, Y. Habu, Y. Koike, K. Motoki, N. Kuranaga, M. Fukasawa, N. Shinomiya, and S. Seki Age-Associated Augmentation of the Synthetic Ligand- Mediated Function of Mouse NK1.1 Ag+ T Cells: Their Cytokine Production and Hepatotoxicity In Vivo and In Vitro J. Immunol., December 1, 2002; 169(11): 6127 - 6132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ogasawara, S. K. Yoshinaga, and L. L. Lanier Inducible Costimulator Costimulates Cytotoxic Activity and IFN-{gamma} Production in Activated Murine NK Cells J. Immunol., October 1, 2002; 169(7): 3676 - 3685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Y. Crowe, M. J. Smyth, and D. I. Godfrey A Critical Role for Natural Killer T Cells in Immunosurveillance of Methylcholanthrene-induced Sarcomas J. Exp. Med., July 1, 2002; 196(1): 119 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sfondrini, D. Besusso, M. T. Zoia, M. Rodolfo, A. M. Invernizzi, M. Taniguchi, T. Nakayama, M. P. Colombo, S. Menard, and A. Balsari Absence of the CD1 Molecule Up-Regulates Antitumor Activity Induced by CpG Oligodeoxynucleotides in Mice J. Immunol., July 1, 2002; 169(1): 151 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. De Creus, K. Van Beneden, F. Stevenaert, V. Debacker, J. Plum, and G. Leclercq Developmental and Functional Defects of Thymic and Epidermal V{gamma}3 Cells in IL-15-Deficient and IFN Regulatory Factor-1-Deficient Mice J. Immunol., June 15, 2002; 168(12): 6486 - 6493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Trobonjaca, A. Kroger, D. Stober, F. Leithauser, P. Moller, H. Hauser, R. Schirmbeck, and J. Reimann Activating Immunity in the Liver. II. IFN-{beta} Attenuates NK Cell-Dependent Liver Injury Triggered by Liver NKT Cell Activation J. Immunol., April 15, 2002; 168(8): 3763 - 3770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Karnbach, M. R. Daws, E. C. Niemi, and M. C. Nakamura Immune Rejection of a Large Sarcoma Following Cyclophosphamide and IL-12 Treatment Requires Both NK and NK T Cells and Is Associated with the Induction of a Novel NK T Cell Population J. Immunol., September 1, 2001; 167(5): 2569 - 2576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nakagawa, I. Nagafune, Y. Tazunoki, H. Ehara, H. Tomura, R. Iijima, K. Motoki, M. Kamishohara, and S. Seki Mechanisms of the Antimetastatic Effect in the Liver and of the Hepatocyte Injury Induced by {{alpha}}-Galactosylceramide in Mice J. Immunol., June 1, 2001; 166(11): 6578 - 6584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hayakawa, K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura Differential Regulation of Th1 and Th2 Functions of NKT Cells by CD28 and CD40 Costimulatory Pathways J. Immunol., May 15, 2001; 166(10): 6012 - 6018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Exley, N. J. Bigley, O. Cheng, S. M. A. Tahir, S. T. Smiley, Q. L. Carter, H. F. Stills, M. J. Grusby, Y. Koezuka, M. Taniguchi, et al. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus J. Leukoc. Biol., May 1, 2001; 69(5): 713 - 718. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Habu, S. Seki, E. Takayama, T. Ohkawa, Y. Koike, K. Ami, T. Majima, and H. Hiraide The Mechanism of a Defective IFN-{{gamma}} Response to Bacterial Toxins in an Atopic Dermatitis Model, NC/Nga Mice, and the Therapeutic Effect of IFN-{{gamma}}, IL-12, or IL-18 on Dermatitis J. Immunol., May 1, 2001; 166(9): 5439 - 5447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Abe, T. Peng, J. Sailors, R. Bucala, and C. N. Metz Regulation of the CTL Response by Macrophage Migration Inhibitory Factor J. Immunol., January 15, 2001; 166(2): 747 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishikawa, H. Hisaeda, M. Taniguchi, T. Nakayama, T. Sakai, Y. Maekawa, Y. Nakano, M. Zhang, T. Zhang, M. Nishitani, et al. CD4+ V{alpha}14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major Int. Immunol., September 1, 2000; 12(9): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Smyth, M. Taniguchi, and S. E. A. Street The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent J. Immunol., September 1, 2000; 165(5): 2665 - 2670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Fuji, Y. Ueda, H. Fujiwara, T. Itoh, T. Yoshimura, and H. Yamagishi Antitumor Effect of {{alpha}}-Galactosylceramide (KRN7000) on Spontaneous Hepatic Metastases Requires Endogenous Interleukin 12 in the Liver Clin. Cancer Res., August 1, 2000; 6(8): 3380 - 3387. [Abstract] [Full Text]
|
|
|
|
|
|
K. Takeda, Y. Hayakawa, M. Atsuta, S. Hong, L. Van Kaer, K. Kobayashi, M. Ito, H. Yagita, and K. Okumura Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12 Int. Immunol., June 1, 2000; 12(6): 909 - 914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Takayama, S. Seki, T. Ohkawa, K. Ami, Y. Habu, T. Yamaguchi, T. Tadakuma, and H. Hiraide Mouse CD8+ CD122+ T Cells with Intermediate TCR Increasing with Age Provide a Source of Early IFN-{gamma} Production J. Immunol., June 1, 2000; 164(11): 5652 - 5658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Smyth, K. Y. T. Thia, S. E.A. Street, E. Cretney, J. A. Trapani, M. Taniguchi, T. Kawano, S. B. Pelikan, N. Y. Crowe, and D. I. Godfrey Differential Tumor Surveillance by Natural Killer (NK) and NKT Cells J. Exp. Med., February 21, 2000; 191(4): 661 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pied, J. Roland, A. Louise, D. Voegtle, V. Soulard, D. Mazier, and P.-A. Cazenave Liver CD4-CD8- NK1.1+ TCR{alpha}{beta} Intermediate Cells Increase During Experimental Malaria Infection and Are Able to Exhibit Inhibitory Activity Against the Parasite Liver Stage In Vitro J. Immunol., February 1, 2000; 164(3): 1463 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Falcone, B. Yeung, L. Tucker, E. Rodriguez, and N. Sarvetnick A Defect in Interleukin 12–induced Activation and Interferon {gamma} Secretion of Peripheral Natural Killer T Cells in Nonobese Diabetic Mice Suggests New Pathogenic Mechanisms for Insulin-dependent Diabetes Mellitus J. Exp. Med., October 4, 1999; 190(7): 963 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Gerber, V. Azuara, J.-P. Levraud, S. Y. Huang, M.-P. Lembezat, and P. Pereira IL-4-Producing {gamma}{delta} T Cells That Express a Very Restricted TCR Repertoire Are Preferentially Localized in Liver and Spleen J. Immunol., September 15, 1999; 163(6): 3076 - 3082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Z. Mehal, A. E. Juedes, and I. N. Crispe Selective Retention of Activated CD8+ T Cells by the Normal Liver J. Immunol., September 15, 1999; 163(6): 3202 - 3210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Doherty, S. Norris, L. Madrigal-Estebas, G. McEntee, O. Traynor, J. E. Hegarty, and C. O'Farrelly The Human Liver Contains Multiple Populations of NK Cells, T Cells, and CD3+CD56+ Natural T Cells with Distinct Cytotoxic Activities and Th1, Th2, and Th0 Cytokine Secretion Patterns J. Immunol., August 15, 1999; 163(4): 2314 - 2321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Hashimoto, T. Osaki, H. Okamura, P. D. Robbins, M. Kurimoto, S. Nagata, M. T. Lotze, and H. Tahara Differential Antitumor Effects of Administration of Recombinant IL-18 or Recombinant IL-12 Are Mediated Primarily by Fas-Fas Ligand- and Perforin-Induced Tumor Apoptosis, Respectively J. Immunol., July 15, 1999; 163(2): 583 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Eberl, R. Lees, S. T. Smiley, M. Taniguchi, M. J. Grusby, and H. R. MacDonald Tissue-Specific Segregation of CD1d-Dependent and CD1d-Independent NK T Cells J. Immunol., June 1, 1999; 162(11): 6410 - 6419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Emoto, H.-W. Mittrucker, R. Schmits, T. W. Mak, and S. H. E. Kaufmann Critical Role of Leukocyte Function-Associated Antigen-1 in Liver Accumulation of CD4+NKT Cells J. Immunol., May 1, 1999; 162(9): 5094 - 5098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kitamura, K. Iwakabe, T. Yahata, S.-i. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, et al. The Natural Killer T (NKT) Cell Ligand alpha -Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells J. Exp. Med., April 5, 1999; 189(7): 1121 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohteki, C. Maki, S. Koyasu, T. W. Mak, and P. S. Ohashi Cutting Edge: LFA-1 Is Required for Liver NK1.1+TCR{alpha}{beta}+ Cell Development: Evidence That Liver NK1.1+TCR{alpha}{beta}+ Cells Originate from Multiple Pathways J. Immunol., April 1, 1999; 162(7): 3753 - 3756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Sempowski, D. M. Lee, R. M. Scearce, D. D. Patel, and B. F. Haynes Resistance of CD7-deficient Mice to Lipopolysaccharide-induced Shock Syndromes J. Exp. Med., March 15, 1999; 189(6): 1011 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Peron, C. Esche, V. M. Subbotin, C. Maliszewski, M. T. Lotze, and M. R. Shurin FLT3-Ligand Administration Inhibits Liver Metastases: Role of NK Cells J. Immunol., December 1, 1998; 161(11): 6164 - 6170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Seki, S.-i. Osada, S. Ono, S. Aosasa, Y. Habu, T. Nishikage, H. Mochizuki, and H. Hiraide Role of Liver NK Cells and Peritoneal Macrophages in Gamma Interferon and Interleukin-10 Production in Experimental Bacterial Peritonitis in Mice Infect. Immun., November 1, 1998; 66(11): 5286 - 5294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Dao, W. Z. Mehal, and I. N. Crispe IL-18 Augments Perforin-Dependent Cytotoxicity of Liver NK-T Cells J. Immunol., September 1, 1998; 161(5): 2217 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ogasawara, K. Takeda, W. Hashimoto, M. Satoh, R. Okuyama, N. Yanai, M. Obinata, K. Kumagai, H. Takada, H. Hiraide, et al. Involvement of NK1+ T Cells and Their IFN-{gamma} Production in the Generalized Shwartzman Reaction J. Immunol., April 1, 1998; 160(7): 3522 - 3527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohteki, H. Yoshida, T. Matsuyama, G. S. Duncan, T. W. Mak, and P. S. Ohashi The Transcription Factor Interferon Regulatory Factor 1 (IRF-1) Is Important during the Maturation of Natural Killer 1.1+ T Cell Receptor-alpha /beta + (NK1+ T) Cells, Natural Killer Cells, and Intestinal Intraepithelial T Cells J. Exp. Med., March 16, 1998; 187(6): 967 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Osaki, J.-M. Peron, Q. Cai, H. Okamura, P. D. Robbins, M. Kurimoto, M. T. Lotze, and H. Tahara IFN-{gamma}-Inducing Factor/IL-18 Administration Mediates IFN-{gamma}- and IL-12-Independent Antitumor Effects J. Immunol., February 15, 1998; 160(4): 1742 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kawamura, K. Takeda, S. K. Mendiratta, H. Kawamura, L. Van Kaer, H. Yagita, T. Abo, and K. Okumura Cutting Edge: Critical Role of NK1+ T Cells in IL-12-Induced Immune Responses In Vivo J. Immunol., January 1, 1998; 160(1): 16 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-G. Yang, J. J. Sergio, D. A. Pearson, G. L. Szot, A. Shimizu, and M. Sykes Interleukin-12 Preserves the Graft-Versus-Leukemia Effect of Allogeneic CD8 T Cells While Inhibiting CD4-Dependent Graft-Versus-Host Disease in Mice Blood, December 1, 1997; 90(11): 4651 - 4660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cui, T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi Requirement for V  14 NKT Cells in IL-12-Mediated Rejection of TumorsScience, November 28, 1997; 278(5343): 1623 - 1626. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
